% alzhub.org library filter
% Source: https://alzhub.org/research?category=clinical-trial&year=2017
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{dardenne2017-28984580,
  author  = {Dardenne, Sophie and Delrieu, Julien and Sourdet, Sandrine and Cantet, Christelle and Andrieu, Sandrine and Mathiex-Fortunet, Hélène and Fougère, Bertrand and Vellas, Bruno},
  title   = {{Memory Complaints and Cognitive Decline: Data from the GUIDAGE Study1}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-170229},
  pmid    = {28984580},
  url     = {https://doi.org/10.3233/jad-170229}
}

@article{nave2017-28550255,
  author  = {Nave, Stephane and Doody, Rachelle S and Boada, Mercè and Grimmer, Timo and Savola, Juha-Matti and Delmar, Paul and Pauly-Evers, Meike and Nikolcheva, Tania and others},
  title   = {{Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-161309},
  pmid    = {28550255},
  url     = {https://doi.org/10.3233/jad-161309}
}

@article{craft2017-28372335,
  author  = {Craft, S. and Claxton, A. and Baker, L. D. and Hanson, A. J. and Cholerton, B. and Trittschuh, E. H. and Dahl, D. and Caulder, E. and others},
  title   = {{Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-161256},
  pmid    = {28372335},
  url     = {https://doi.org/10.3233/jad-161256}
}

@article{abushakra2017-29182706,
  author  = {Abushakra, S and Porsteinsson, A and Scheltens, P and Sadowsky, C and Vellas, B and Cummings, J and Gauthier, S and Hey, J A and others},
  title   = {{Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2017},
  doi     = {10.14283/jpad.2017.26},
  pmid    = {29182706},
  url     = {https://doi.org/10.14283/jpad.2017.26}
}

@article{relkin2017-28381506,
  author  = {Relkin, Norman R and Thomas, Ronald G and Rissman, Robert A and Brewer, James B and Rafii, Michael S and van Dyck, Christopher H and Jack, Clifford R and Sano, Mary and others},
  title   = {{A phase 3 trial of IV immunoglobulin for Alzheimer disease}},
  journal = {Neurology},
  year    = {2017},
  doi     = {10.1212/wnl.0000000000003904},
  pmid    = {28381506},
  url     = {https://doi.org/10.1212/wnl.0000000000003904}
}

@article{sawda2017-28815614,
  author  = {Sawda, Christine and Moussa, Charbel and Turner, R Scott},
  title   = {{Resveratrol for Alzheimer's disease}},
  journal = {Annals of the New York Academy of Sciences},
  year    = {2017},
  doi     = {10.1111/nyas.13431},
  pmid    = {28815614},
  url     = {https://doi.org/10.1111/nyas.13431}
}

@article{gold2017-29067346,
  author  = {Gold, Michael},
  title   = {{Phase II clinical trials of anti-amyloid β antibodies: When is enough, enough?}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2017},
  doi     = {10.1016/j.trci.2017.04.005},
  pmid    = {29067346},
  url     = {https://doi.org/10.1016/j.trci.2017.04.005}
}